| Product Code: ETC13362928 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Oncology Companion Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Oncology Companion Diagnostics Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Oncology Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Oncology Companion Diagnostics Market - Industry Life Cycle |
3.4 Europe Oncology Companion Diagnostics Market - Porter's Five Forces |
3.5 Europe Oncology Companion Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Oncology Companion Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Europe Oncology Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Europe Oncology Companion Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Europe Oncology Companion Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
4 Europe Oncology Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Oncology Companion Diagnostics Market Trends |
6 Europe Oncology Companion Diagnostics Market, 2021 - 2031 |
6.1 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By PCR-Based, 2021 - 2031 |
6.1.3 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By NGS-Based, 2021 - 2031 |
6.1.4 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By IHC-Based, 2021 - 2031 |
6.1.5 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By FISH-Based, 2020 - 2028 |
6.2 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.2.3 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.4 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Colorectal Cancer, 2021 - 2031 |
6.2.5 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Ovarian Cancer, 2021 - 2031 |
6.3 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Research Centers, 2021 - 2031 |
6.3.4 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Diagnostic Labs, 2021 - 2031 |
6.3.5 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Blood, 2021 - 2031 |
6.4.3 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Tissue, 2021 - 2031 |
6.4.4 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Saliva, 2020 - 2028 |
6.4.5 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Urine, 2020 - 2028 |
7 Europe Oncology Companion Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.1 United Kingdom (UK) Oncology Companion Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.2 Germany Oncology Companion Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.3 France Oncology Companion Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.4 Poland Oncology Companion Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.5 Spain Oncology Companion Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.6 Rest of Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3 Europe Oncology Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
7.3.1 United Kingdom (UK) Oncology Companion Diagnostics Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3.2 Germany Oncology Companion Diagnostics Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3.3 France Oncology Companion Diagnostics Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3.4 Poland Oncology Companion Diagnostics Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3.5 Spain Oncology Companion Diagnostics Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3.6 Rest of Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.4 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United Kingdom (UK) Oncology Companion Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Germany Oncology Companion Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 France Oncology Companion Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Poland Oncology Companion Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Spain Oncology Companion Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Rest of Europe Oncology Companion Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5.1 United Kingdom (UK) Oncology Companion Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5.2 Germany Oncology Companion Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5.3 France Oncology Companion Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5.4 Poland Oncology Companion Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5.5 Spain Oncology Companion Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5.6 Rest of Europe Oncology Companion Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
8 Europe Oncology Companion Diagnostics Market Key Performance Indicators |
9 Europe Oncology Companion Diagnostics Market - Export/Import By Countries Assessment |
10 Europe Oncology Companion Diagnostics Market - Opportunity Assessment |
10.1 Europe Oncology Companion Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Oncology Companion Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.3 Europe Oncology Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
10.4 Europe Oncology Companion Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Europe Oncology Companion Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
11 Europe Oncology Companion Diagnostics Market - Competitive Landscape |
11.1 Europe Oncology Companion Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 Europe Oncology Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here